acetylgalactosamine has been researched along with Chagas Cardiomyopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allahdadi, KJ; Aragão França, L; Azevedo, CM; Carvalho, RH; da Silva, KN; de Souza Neto, JD; Dos Santos, RR; Macambira, SG; Meira, CS; Neto, PC; Paredes, BD; Sampaio, GLA; Silva, DN; Soares, MBP; Souza, BSF; Tavora, F; Vasconcelos, JF | 1 |
1 other study(ies) available for acetylgalactosamine and Chagas Cardiomyopathy
Article | Year |
---|---|
Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy.
Topics: Acetylgalactosamine; Animals; Cell Proliferation; Cell Survival; Chagas Cardiomyopathy; Chronic Disease; Collagen Type I; Fibrosis; Galectin 3; Heart Transplantation; Humans; Macrophages; Mice; Mice, Inbred C57BL; Myocarditis; Myocardium; Myofibroblasts; T-Lymphocytes | 2017 |